- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04176302
Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial (MoMoPa-EC)
When Parkinson Disease is mild, it responds well to treatment with drugs (L-Dopa and dopamine antagonists). However, as the disease progresses, the effect of the drugs diminishes and lasts for a shorter time (wearing-off), which require physicians to progressively increase and/or break up the dosage of dopamine drugs, to control symptoms over the course of the entire day. Despite this, most patients present motor fluctuations after 10 years. These fluctuations consist of changes between what are known as Off periods, when the medication does not produce an effect and mobility is hindered, and On periods when patients can move smoothly, with the medication producing its best effect.
The timeline of these motor fluctuations over the course of the day and also on different days is very valuable to precisely adjust the medication. Nevertheless, neurologists do not currently have detailed information on the timeline of the symptoms of their patients, which means that they have serious difficulties to obtain good results with the adjustment of medication. Currently, the neurologist's information on the time progression of the motor fluctuations is drawn from what the patient indicates in the office visit, or in the best case, from diaries that the patient fills out at home, periodically (e.g. every hour) noting the motor state (On or Off). Although the latter method is still the gold standard in research and in care, it has serious limitations, because patients often forget to record the information (especially when they are in Off), many do not recognize their motor states well, and few can maintain adherence to such a laborious system for more than a few days.
The Parkinson Holter (STAT-ON ®) is a wearable device, which objectively measures and records the motor fluctuations of the patients. It does not require intervention by the patient, and can, therefore, be used in daily life, long term if necessary. However, the concept that detailed knowledge of motor fluctuations of patients will lead to better control of the disease, thanks to optimisation of the therapeutic regimen, is still a hypothesis. To demonstrate or refute this hypothesis, we are now conducting a clinical trial, with this medical device, to study the clinical effectiveness in patients with moderate Parkinson's disease and motor fluctuations. This trial will show whether using the Parkinson Holter is better than the clinical interview used in traditional clinical practice (primary objective), and whether it is not inferior to the On-Off diary recorded by the patients at home (exploratory objective)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alejandro Rodríguez-Molinero, PhD/MD
- Phone Number: 34-938940025
- Email: arodriguez@csapg.cat
Study Locations
-
-
-
Alicante, Spain
- Recruiting
- Hospital General Universitario de Alicante
-
Principal Investigator:
- Silvia Martí Martínez, PhD/MD
-
Alicante, Spain
- Recruiting
- Hospital General de Elche
-
Principal Investigator:
- María Álvarez Saúco, PhD/MD
-
Badalona, Spain
- Not yet recruiting
- Hospital Universitari Germans Trias i Pujol
-
Principal Investigator:
- Lourdes M Ispierto González, PhD/MD
-
Barcelona, Spain
- Recruiting
- Hospital Universitari Vall d'Hebron
-
Principal Investigator:
- Jorge Hernández-Vara, PhD/MD
-
Barcelona, Spain
- Recruiting
- Hospital del Mar
-
Principal Investigator:
- Víctor M Puente Periz, PhD/MD
-
Barcelona, Spain
- Recruiting
- Hospital de la Santa Creu i Sant Pau
-
Principal Investigator:
- Alexandre Gironell Carreró, PhD/MD
-
Barcelona, Spain
- Recruiting
- Hospital Moisès Broggi - CS Integral
-
Principal Investigator:
- Nuria Caballol Pons, PhD/MD
-
Barcelona, Spain
- Not yet recruiting
- Hospital Sanitas Cima
-
Principal Investigator:
- Pilar M Quilez Ferrer, PhD/MD
-
Barcelona, Spain
- Recruiting
- Terapia Integral UParkinson, SL
-
Principal Investigator:
- Angels M Bayés Rusiñol, PhD/MD
-
Burgos, Spain
- Recruiting
- Hospital Universitario De Burgos
-
Principal Investigator:
- Esther M Cubo Delgado, PhD/MD
-
Girona, Spain
- Not yet recruiting
- Hospital Universitari Dr. Josep Trueta
-
Principal Investigator:
- Berta M Solano Vila, PhD/MD
-
Huelva, Spain
- Not yet recruiting
- Hospital Universitario Juan Ramon Jimenez
-
Principal Investigator:
- Juan Manuel Oropesa Ruiz, PhD/MD
-
Madrid, Spain
- Recruiting
- Hospital Universitario 12 de Octubre
-
Principal Investigator:
- David A Pérez-Martínez, PhD/MD
-
Madrid, Spain
- Recruiting
- Hospital Universitario Ramon y Cajal
-
Principal Investigator:
- Juan Carlos Martínez-Castrillo, PhD/MD
-
Madrid, Spain
- Recruiting
- Hospital Clinico San Carlos
-
Principal Investigator:
- Rocío García Ramos, PhD/MD
-
Madrid, Spain
- Not yet recruiting
- Hospital Universitario La Princesa
-
Principal Investigator:
- Lydia M López Manzanares, PhD/MD
-
Madrid, Spain
- Not yet recruiting
- Hospital Universitario Fundación Jiménez Díaz
-
Principal Investigator:
- Pedro J. García Ruíz Espiga, PhD/MD
-
Madrid, Spain
- Not yet recruiting
- Hospital Universitario del Henares
-
Principal Investigator:
- Elvira García Cobos, PhD/MD
-
Madrid, Spain
- Recruiting
- Hospital Universitario La Moraleja
-
Principal Investigator:
- Esteban M Peña Llamas, PhD/MD
-
Málaga, Spain
- Recruiting
- Hospital Universitario Virgen de la Victoria
-
Principal Investigator:
- Mª José Gómez Heredia, PhD/MD
-
Málaga, Spain
- Recruiting
- Hospital Regional Universitario de Malaga
-
Principal Investigator:
- Teresa Muñoz Ruiz, PhD/MD
-
San Sebastián De Los Reyes, Spain
- Recruiting
- Hospital Universitario Infanta Sofía
-
Principal Investigator:
- Marina M Mata Álvarez-Santullano, PhD/MD
-
Sant Boi De Llobregat, Spain
- Not yet recruiting
- Hospital General Parc Sanitari Sant Joan de Déu
-
Principal Investigator:
- Antoni M Callén Soto, Phd/MD
-
Sant Cugat Del Vallès, Spain
- Not yet recruiting
- Hospital Universitari General de Catalunya
-
Principal Investigator:
- Ernest M Balaguer Martínez, PhD/MD
-
Sevilla, Spain
- Recruiting
- Hospital Universitario Virgen del Rocio
-
Principal Investigator:
- Pablo Mir Rivera, PhD/MD
-
Terrassa, Spain
- Not yet recruiting
- Consorci Sanitari de Terrassa
-
Principal Investigator:
- Gabriel M Salazar Tortolero, PhD/MD
-
Toledo, Spain
- Recruiting
- Hospital Virgen de la Salud
-
Principal Investigator:
- Núria López Ariztegui, PhD/MD
-
Valencia, Spain
- Recruiting
- Hospital Clinico Universitario de Valencia
-
Principal Investigator:
- José María Salom, PhD/MD
-
Valencia, Spain
- Recruiting
- Hospital de Llíria
-
Principal Investigator:
- Mª Pilar Solís Pérez, PhD/MD
-
Zaragoza, Spain
- Recruiting
- Hospital Royo de Vilanova
-
Principal Investigator:
- Alfredo López López, PhD/MD
-
-
Barcelona
-
Hospitalet de Llobregat, Barcelona, Spain
- Recruiting
- Hospital General de l'Hospitalet. CS Integral
-
Principal Investigator:
- Asunción Ávila, PhD/MD
-
Mataró, Barcelona, Spain
- Not yet recruiting
- Consorci Sanitari del Maresme. Hospital de Mataró
-
Principal Investigator:
- Pilar M Sanz Cartagena, PhD/MD
-
Terrassa, Barcelona, Spain
- Recruiting
- Hospital Universitari Mutua Terrassa
-
Principal Investigator:
- Pau Pastor, PhD/MD
-
Principal Investigator:
- Maria Teresa Buongiorno, PhD/MD
-
Vilafranca Del Penedès, Barcelona, Spain
- Recruiting
- Consorci Sanitari de l'Alt Penedès i Garraf
-
Principal Investigator:
- Alfons Moral, PhD/MD
-
-
Cantabria
-
Santander, Cantabria, Spain
- Recruiting
- Hospital Universitario Marqués de Valdecilla
-
Principal Investigator:
- Jon Infante Ceberio, PhD/MD
-
-
Ciudad Real
-
Alcázar De San Juan, Ciudad Real, Spain
- Recruiting
- Hospital General La Mancha-Centro, Alcázar de San Juan
-
Principal Investigator:
- Marta Recio Bermejo, PhD/MD
-
-
Galicia
-
Lugo, Galicia, Spain
- Recruiting
- Hospital Universitario Lucus Augusti
-
Principal Investigator:
- Jessica González Ardura, PhD/MD
-
-
Guipúzkoa
-
Donostia, Guipúzkoa, Spain
- Not yet recruiting
- Hospital Universitario de Donostia
-
Principal Investigator:
- Javier Ruíz Martínez, PhD/MD
-
-
Madrid
-
Alcorcón, Madrid, Spain
- Recruiting
- Hospital Universitario Fundacion Alcorcon
-
Principal Investigator:
- Lydia M Vela Desojo, PhD/MD
-
Majadahonda, Madrid, Spain
- Recruiting
- Hospital Universitario Puerta de Hierro, Majadahonda
-
Principal Investigator:
- Pilar Sánchez Alonso, PhD/MD
-
-
Murcia
-
El Palmar, Murcia, Spain
- Not yet recruiting
- Hospital Univesitario Virgen de la Arrixaca
-
Principal Investigator:
- José María López, PhD/MD
-
-
Pontevedra
-
Vigo, Pontevedra, Spain
- Recruiting
- Hospital Álvaro Cunqueiro
-
Principal Investigator:
- Antonio Kouloulis Fernández, PhD/MD
-
-
Tarragona
-
Tortosa, Tarragona, Spain
- Recruiting
- Hospital Verge de la Cinta
-
Principal Investigator:
- Sonia M Escalante Arroyo, PhD/MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ideopathic Parkinson's Disease
- Disease in the moderate-severe phase (Hoehn & Yahr ≥ 2 en Off)
- Motor fluctuations (with at least 2h/day in Off)
- Agree to participate voluntarily and will sign a written consent form
Exclusion Criteria:
- Incapable of walking independently or H&Y=5
- Participating in another clinical trial
- Patients with acute intercurrent disease
- Psychiatric or cognitive disorders that prevent collaboration (MMSE <24)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Parkinson Holter
The neurologists in the study will receive information from the Parkinson Holter (device being studied)
|
The neurologists will receive the wearable report (for medication adjustment, if any as per physician's criteria/judgement)
Other Names:
|
Active Comparator: Parkinson's diary
The neurologists in the study will receive information from a motor fluctuations diary
|
The neurologists will receive the patient's diary report (for medication adjustment, if any as per physician's criteria/judgement).
Other Names:
|
Placebo Comparator: Traditional clinical practice
The neurologists in the study will receive no additional information other than what is obtained during the visit
|
The neurologists will receive the patient & caregiver report at the time of the visit (for medication adjustment, if any as per physician's criteria/judgement).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily time in Off
Time Frame: 7 days
|
Changes from baseline to last visit in daily hours in Off
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of clinical contacts
Time Frame: 6 months
|
Number of patient visits and telephone controls to adjust medication
|
6 months
|
Patient's adherence to the MF measurement system
Time Frame: 7 days
|
Total hour/days with information registered.
|
7 days
|
Number of therapeutic changes.
Time Frame: 6 months
|
Number of therapeutic changes done to improve symptoms.
|
6 months
|
Motor complications
Time Frame: 6 months
|
Changes from baseline to last visit in motor complications, assessed by means of Unified Parkinson's Disease Rating Scale - part IV
|
6 months
|
Daily time in On
Time Frame: 7 days
|
Changes from baseline to last visit in daily hours in On
|
7 days
|
Change of presence and severity of freezing of gait episodes
Time Frame: 7 days
|
Changes from baseline to last visit in the number and severity of freezing of gait episodes, assessed by means of Freezing of Gait Questionnaire
|
7 days
|
Reported quality of life
Time Frame: 1 month
|
Changes from baseline to last visit in quality of life, assessed by menas of Parkinson's Disease Questionnaire-39
|
1 month
|
Activities of Daily Living
Time Frame: 6 months
|
Changes from baseline to last visit in dependence for Activities of Daily Living assessed by means of Unified Parkinson's Disease Rating Scale - part II
|
6 months
|
User satisfaction: Quebec User Evaluation of Satisfaction with assistive Technology
Time Frame: 7 days
|
Physician and patient satisfaction with the Parkinson Holter will be assessed by means of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST)
|
7 days
|
System usability: System Usability Scale
Time Frame: 7 days
|
Usability of the system will be assessed by System Usability Scale (SUS)
|
7 days
|
Collaborators and Investigators
Investigators
- Study Director: Alejandro Rodríguez-Molinero, PhD/MD, Consorci Sanitari de l'Alt Penedès i Garraf
Publications and helpful links
General Publications
- Perez-Lopez C, Hernandez-Vara J, Caballol N, Bayes A, Buongiorno M, Lopez-Ariztegui N, Gironell A, Lopez-Sanchez J, Martinez-Castrillo JC, Sauco M A, Lopez-Manzanares L, Escalante-Arroyo S, Perez-Martinez DA, Rodriguez-Molinero A; MoMoPa-EC Research Group. Comparison of the Results of a Parkinson's Holter Monitor With Patient Diaries, in Real Conditions of Use: A Sub-analysis of the MoMoPa-EC Clinical Trial. Front Neurol. 2022 May 16;13:835249. doi: 10.3389/fneur.2022.835249. eCollection 2022.
- Rodriguez-Molinero A, Hernandez-Vara J, Minarro A, Perez-Lopez C, Bayes-Rusinol A, Martinez-Castrillo JC, Perez-Martinez DA; Monitoring Parkinson's patients Mobility for therapeutic purposes research group. Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods: study protocol. BMJ Open. 2021 Jul 19;11(7):e045272. doi: 10.1136/bmjopen-2020-045272.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INV_PROC_A118
- DTS17/00195 (Other Grant/Funding Number: Instituto de Salud Carlos III - European Regional Development Fund (ERDF))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Parkinson Holter
-
Sahlgrenska University Hospital, SwedenCompletedParkinson DiseaseSweden
-
Zuyderland Medisch CentrumAbbVieActive, not recruitingParkinson DiseaseNetherlands
-
University of BristolRadboud University Medical CenterActive, not recruiting
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease
-
Institute for Neurodegenerative DisordersCompletedParkinson DiseaseUnited States
-
Somogy Megyei Kaposi Mór Teaching HospitalUniversity Medical Center GroningenCompletedParkinson Disease | Rehabilitation | Follow up
-
University Hospital, LilleGroupement Interrégional de Recherche Clinique et d'Innovation; french patient...Not yet recruiting
-
Xiamen UniversityNot yet recruitingParkinson Disease | Anxiety
-
Centre Hospitalier Universitaire DijonCompletedSeptic Shock | Atrial FibrillationFrance